Gastrointestinal events in at-risk patients starting non-steroidal anti-inflammatory drugs (NSAIDs) for rheumatic diseases: the EVIDENCE study of European routine practice
Ángel LanasMaarten BoersDepartments of Epidemiology and Biostatistics and Rheumatology, VU University Medical Center, Amsterdam, The NetherlandsJavier NuevoObservational Research Centre, Global Medicines Development, AstraZeneca, Madrid, Spain
2013en
ABI
Аннотация
Аннотация мавжуд эмас.
Идентификаторлар
Иқтибослар ва манбалар
2 та иқтибос0 та фойдаланилган манба